Ferroptosis contributes to the progression of female-specific neoplasms, from breast cancer to gynecological malignancies in a manner regulated by non-coding RNAs: Mechanistic implications
Kiavash Hushmandi,Daniel J. Klionsky,Amir Reza Aref,Mojtaba Bonyadi,Russel J. Reiter,Noushin Nabavi,Shokooh Salimimoghadam,Seyed Hassan Saadat
DOI: https://doi.org/10.1016/j.ncrna.2024.05.008
2024-05-22
Non-coding RNA Research
Abstract:Highlights • Ferroptosis is a non-apoptotic cell death process with crucial roles in the progression of female-oriented cancers, including breast and gynecological malignancies. • Non-coding RNAs (ncRNAs), a diverse class of RNA transcripts that do not encode proteins, have emerged as key modulators of ferroptosis. • NcRNAs, especially microRNAs, long non-coding RNAs, and circular RNAs principally regulate the ferroptotic flux by controlling the expression of genes involved in lipid metabolism, oxidative stress, and cellular redox signaling pathways. • Over- and/or under-expression of these ncRNAs affects ferroptosis, promoting tumor growth, invasion, and metastasis in female-specific cancers. • Targeting these ncRNAs holds promise as a new therapeutic approach for counteracting the development and progression of female-specific malignancies. Ferroptosis, a recently identified type of non-apoptotic cell death, triggers the elimination of cells in the presence of lipid peroxidation and in an iron-dependent manner. Indeed, ferroptosis-stimulating factors have the ability of suppressing antioxidant capacity, leading to the accumulation of reactive oxygen species (ROS) and the subsequent oxidative death of the cells. Ferroptosis is involved in the pathophysiological basis of different maladies, such as multiple cancers, among which female-oriented malignancies have attracted much attention in recent years. In this context, it has also been unveiled that non-coding RNA transcripts, including microRNAs, long non-coding RNAs, and circular RNAs have regulatory interconnections with the ferroptotic flux, which controls the pathogenic development of diseases. Furthermore, the potential of employing these RNA transcripts as therapeutic targets during the onset of female-specific neoplasms to modulate ferroptosis has become a research hotspot; however, the molecular mechanisms and functional alterations of ferroptosis still require further investigation. The current review comprehensively highlights ferroptosis and its association with non-coding RNAs with a focus on how this crosstalk affects the pathogenesis of female-oriented malignancies, from breast cancer to ovarian, cervical, and endometrial neoplasms, suggesting novel therapeutic targets to decelerate and even block the expansion and development of these tumors. Graphical abstract Download : Download high-res image (117KB) Download : Download full-size image
biochemistry & molecular biology